Infectious Diseases

A combination of recombinant interferon beta-1b and lopinavir–ritonavir reduced mortality in patients with Middle East respiratory syndrome (MERS) compared to placebo, according to a study published in the New England Journal of Medicine. Treatment was most successful when started within the first 7 days of symptom onset.

In this a randomized, adaptive, double-blind, placebo-controlled trial, 95 patients with MERS were randomly assigned to receive…

View Conference Coverage

Take a look at some of our conference coverage, visit our roundup section.

Conference Roundup

  1. Feb 27, 2020

Researchers Identify Biomarkers of Acute Flaccid Myelitis

The biological signature of acute flaccid myelitis (AFM) found in cerebrospinal fluid has been identified by researchers, according to a presentation at IDWeek 2019. The findings also helped researchers distinguish between the specific enteroviruses that have been associated with AFM…

Journal Scan

  1. Oct 07, 2020

Combination treatment reduces mortality in hospitalized patients with MERS

A combination of recombinant interferon beta-1b and lopinavir–ritonavir reduced mortality in patients with Middle East respiratory syndrome (MERS) compared to placebo, according to a study published in the New England Journal of Medicine. Treatment was most…